Changes in gene expression during the development of mammary tumors in MMTV-Wnt-1 transgenic mice

[1]  Kathleen R. Cho,et al.  FGF‐20 and DKK1 are transcriptional targets of β‐catenin and FGF‐20 is implicated in cancer and development , 2005, The EMBO journal.

[2]  F. Kittrell,et al.  From Mice to Humans , 2004, Cancer Research.

[3]  Lajos Pusztai,et al.  Improving patient care through molecular diagnostics. , 2004, Seminars in oncology.

[4]  H. Varmus,et al.  Evolution of somatic mutations in mammary tumors in transgenic mice is influenced by the inherited genotype , 2004, BMC medicine.

[5]  K. Brennan,et al.  Wnt Proteins in Mammary Development and Cancer , 2004, Journal of Mammary Gland Biology and Neoplasia.

[6]  Bob Y. Liu,et al.  The transforming activity of Wnt effectors correlates with their ability to induce the accumulation of mammary progenitor cells , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[7]  R. Nusse,et al.  Convergence of Wnt, ß-Catenin, and Cadherin Pathways , 2004, Science.

[8]  H. Varmus,et al.  Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[9]  Alan Ashworth,et al.  Stem cells and breast cancer: A field in transit , 2003, Nature Reviews Cancer.

[10]  Philip M. Long,et al.  Breast cancer classification and prognosis based on gene expression profiles from a population-based study , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Dennis C. Sgroi,et al.  Laser Capture Microdissection and Advanced Molecular Analysis of Human Breast Cancer , 2003, Journal of Mammary Gland Biology and Neoplasia.

[12]  G. Dontu,et al.  In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. , 2003, Genes & development.

[13]  R. Salunga,et al.  Gene expression profiles of human breast cancer progression , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Kornelia Polyak,et al.  Molecular markers in ductal carcinoma in situ of the breast. , 2003, Molecular cancer research : MCR.

[15]  M. Gazouli,et al.  The complement inhibitor CD59 and the lymphocyte function-associated antigen-3 (LFA-3, CD58) genes possess functional binding sites for the p53 tumor suppressor protein. , 2002, Anticancer research.

[16]  Robert D Cardiff,et al.  Pathway pathology: histological differences between ErbB/Ras and Wnt pathway transgenic mammary tumors. , 2002, The American journal of pathology.

[17]  Michael L. Bittner,et al.  Ratio statistics of gene expression levels and applications to microarray data analysis , 2002, Bioinform..

[18]  Jonathan R Pollack,et al.  A transcriptional response to Wnt protein in human embryonic carcinoma cells , 2002, BMC Developmental Biology.

[19]  Richard Simon,et al.  Initiating oncogenic event determines gene-expression patterns of human breast cancer models , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[20]  J. Winer,et al.  Synergistic Induction of Tumor Antigens by Wnt-1 Signaling and Retinoic Acid Revealed by Gene Expression Profiling* , 2002, The Journal of Biological Chemistry.

[21]  P. Leder,et al.  β-catenin is a downstream effector of Wnt-mediated tumorigenesis in the mammary gland , 2001, Oncogene.

[22]  J. Marks,et al.  A SAGE (serial analysis of gene expression) view of breast tumor progression. , 2001, Cancer research.

[23]  T. Pham,et al.  Overexpression of the retinoic acid-responsive gene Stra6 in human cancers and its synergistic induction by Wnt-1 and retinoic acid. , 2001, Cancer research.

[24]  E. Dougherty,et al.  Gene-expression profiles in hereditary breast cancer. , 2001, The New England journal of medicine.

[25]  H. Varmus,et al.  Deficiency of Pten accelerates mammary oncogenesis in MMTV-Wnt-1 transgenic mice , 2001, BMC Molecular Biology.

[26]  L. Donehower,et al.  Differential gene expression in mouse mammary adenocarcinomas in the presence and absence of wild type p53 , 2000, Oncogene.

[27]  N. Lee,et al.  Identification of c-myc responsive genes using rat cDNA microarray. , 2000, Cancer research.

[28]  Monilola A. Olayioye,et al.  The ErbB signaling network: receptor heterodimerization in development and cancer , 2000, The EMBO journal.

[29]  H. Varmus,et al.  Use of MMTV-Wnt-1 transgenic mice for studying the genetic basis of breast cancer , 2000, Oncogene.

[30]  R. Cardiff,et al.  The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting‡ , 2000, Oncogene.

[31]  J. Hudson,et al.  In vivo gene expression profile analysis of human breast cancer progression. , 1999, Cancer research.

[32]  H. Varmus,et al.  Development of a flexible and specific gene delivery system for production of murine tumor models , 1999, Oncogene.

[33]  C. Albanese,et al.  The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[34]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[35]  A. Sparks,et al.  Identification of c-MYC as a target of the APC pathway. , 1998, Science.

[36]  Jan E Schnitzer,et al.  Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells , 1998, Oncogene.

[37]  P. Brown,et al.  Exploring the metabolic and genetic control of gene expression on a genomic scale. , 1997, Science.

[38]  P. Chambon,et al.  Developmental expression pattern of Stra6, a retinoic acid-responsive gene encoding a new type of membrane protein , 1997, Mechanisms of Development.

[39]  D. Pinkel,et al.  Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability. , 1995, Genes & development.

[40]  R. Cardiff,et al.  Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[41]  Roel Nusse,et al.  Wnt genes , 1992, Cell.

[42]  H. Varmus,et al.  Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice , 1988, Cell.

[43]  W. McGuire,et al.  Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. , 1987, Science.

[44]  Harold E. Varmus,et al.  Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome , 1982, Cell.

[45]  R. Nusse,et al.  Convergence of Wnt, beta-catenin, and cadherin pathways. , 2004, Science.

[46]  Minoti Hiremath,et al.  Beta-catenin and Tcfs in mammary development and cancer. , 2003, Journal of mammary gland biology and neoplasia.

[47]  F. McCormick,et al.  Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. , 1999, Nature.